Shanghai Junshi Biosciences Enters Contract for Cancer Drug Distribution in Europe

MT NewswiresJan 21 05:55 ET

Zhihui Hong Kong Stock Early Insights | Two Departments: Establish a pricing mechanism for public data resource authorization Operation. LINGBAO GOLD (03330) announces a profit warning.

The National Development and Reform Commission and the National Bureau of Statistics issued a notice on establishing a pricing mechanism for the authorized operation of public data resources.

Zhitong FinanceJan 20 19:05 ET

Announcement selection | New China Life Insurance expects a year-on-year profit increase of over 175% in 2024; LINGBAO GOLD is expected to see net income increase year-on-year by about 110% to 140%.

New China Life Insurance expects a year-on-year profit increase of over 175% in 2024; CHI MER LAND's annual sales exceed 42 billion yuan.

cls.cnJan 20 19:04 ET

JUNSHI BIO (01877) has signed a distribution and commercialization agreement for Trelagliptin with LEO Pharma.

JUNSHI BIO (01877) announced that recently, its wholly-owned subsidiary TopAlliance Bio...

Zhitong FinanceJan 20 07:49 ET

Express News | Shanghai Junshi Biosciences - Entering Into Distribution and Marketing Agreement With Leo Pharma

ReutersJan 20 07:46 ET

Express News | Junshi Biosciences Announces Commercialization Partnership With Leo Pharma for Toripalimab in Europe

ReutersJan 20 06:12 ET